VIVE Insider Trading - Viveve Medical, Inc.

Deler fremragende	10,752,664 shares
Insideraktier	9.862.898 shares
Insider ejerskab	91,73 %
Total Insiders	39

Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Se Højest rangerende aktier

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Se Højest rangerende aktier

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )

6190 out of 10963

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )

6093 out of 10830

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Viveve Medical, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider	Aktier Ejet	Dele Justeret
5am Co-investors Ii Lp 10% Owner - [10%]	288.447	288.447
5AM Partners II, LLC 10% Owner - [10%]	288.447	288.447
5AM Ventures II LP 10% Owner - [10%]	288.447	288.447
Alta Bioequities Management, LLC 10% Owner - [10%]	5.455.632	5.455.632
Alta Bioequities, L.P. 10% Owner - [10%]	5.455.632	5.455.632
Atkinson James G. CBO & President - [O]	53.945	981
Lori H Bush Director - [D]	6.530	119
Steven L Basta Director - [D]	25	25
Mark Samuel Colella Director, 10% Owner - [D] [10%]	288.447	288.447
John D Diekman 10% Owner - [10%]	288.447	288.447
Kevin J Dunn	22.500
Scott Durbin Chief Executive Officer - [O]	10	10
Bioventures III A/C GBS 10% Owner - [10%]	7.952.805	3.598.807

Insider	Aktier Ejet	Dele Justeret
GBS Venture Partners Pty, Ltd 10% Owner - [10%]	3.598.807	3.598.807
Sachs & Co Goldman 10% Owner - [10%]	23.688	5.304
Goldman Sachs Group Inc -	53.042	5.304
Benjamin L Holmes	515.300
Daniel Janney Director, 10% Owner - [D] [10%]	60.579	1.101
Debora Jorn Director - [D]	40.109	729
Timothy P Lynch 10% Owner - [10%]	3.849.711	69.995
Daniel Mack 10% Owner - [10%]	6.581.465	119.663
Mann Gregory W.	1.492.377
Arlene Morris Director - [D]	2.482	45
H B Brent Norton	409.000
Nantahala Capital Management, LLC 10% Owner - [10%]	6.581.465	119.663
Edward H Pendergast	45.000

Insider	Aktier Ejet	Dele Justeret
Jon M Plexico Director, 10% Owner - [D] [10%]	22.548	410
Sharon Collins Presnell	18.000
Vincent Puglisi	609.902
Scott M Rocklage 10% Owner - [10%]	288.447	288.447
Jim B Robbins SVP, Finance & Administration - [O]	0	0
Stonepine Capital, L.p. 10% Owner - [10%]	3.849.711	69.995
Patricia Scheller Chief Executive Officer, Director - [D] [O]	45.164	821
Schwab Andrew J. 10% Owner - [10%]	288.447	288.447
Carl Simpson Director - [D]	30.768	30.768
Brigitte Smith Director - [D]	25.312	460
Stonepine Capital Management, LLC Director, 10% Owner - [D] [10%]	3.849.711	69.995
Mark R Tauscher	3.537.565
Zaderej Karen L. Director - [D]	62.347	1.134

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i VIVE / Viveve Medical, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato	Insider	Rapporteret Aktier	Rapporteret Pris	Justeret Aktier	Justeret Pris	Omkostningsgrundlag	dage til Maks	Pris kl Maks	Maks Fortjeneste ($)	Maks. afkast (%)
2019-09-24	GOLDMAN SACHS GROUP INC	25.400	5,6500	2.540	56,5000	143.510	330	5.785	-128.816	-89,76
2019-09-24	GOLDMAN SACHS GROUP INC	26.200	5,6400	2.620	56,4000	147.768
2019-09-23	GOLDMAN SACHS GROUP INC	38.800	5,8400	3.880	58,4000	226.592
2019-09-23	GOLDMAN SACHS GROUP INC	39.600	5,8400	3.960	58,4000	231.264
2017-08-23	Durbin Scott	5.000	5,2500	91	288,7500	26.250
2017-03-17	Stonepine Capital Management, LLC	1.250.000	4,0000	22.727	220,0000	5.000.000
2017-03-17	JANNEY DANIEL	500.000	4,0000	9.091	220,0000	2.000.000
2017-03-17	Scheller Patricia	12.500	4,0000	227	220,0000	50.000
2017-03-17	Atkinson James G.	187.500	4,0000	3.409	220,0000	750.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VIVE / Viveve Medical, Inc. Insider Trades

Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i VIVE / Viveve Medical, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato	Insider	Rapporteret Aktier	Rapporteret Pris	Justeret Aktier	Justeret Pris	Omkostningsgrundlag	dage til Min	Pris kl Min	Max tab Undgået ($)	Max tab Undgået (%)
2019-10-01	GOLDMAN SACHS GROUP INC	23.688	5,5600	2.369	55,6000	131.705	359	0.5079	-130.502	-99,09
2019-10-01	GOLDMAN SACHS GROUP INC	25	5,7700	2	57,7000	144
2019-10-01	GOLDMAN SACHS GROUP INC	23.663	5,5600	2.366	55,6000	131.566
2019-09-30	GOLDMAN SACHS GROUP INC	68.737	4,5500	6.874	45,5000	312.753
2019-09-27	GOLDMAN SACHS GROUP INC	5.359	5,0200	536	50,2000	26.902
2019-09-27	GOLDMAN SACHS GROUP INC	5.359	5,1000	536	51,0000	27.331
2019-09-26	GOLDMAN SACHS GROUP INC	7.001	5,2500	700	52,5000	36.755
2019-09-25	GOLDMAN SACHS GROUP INC	10.799	5,6300	1.080	56,3000	60.798
2019-09-25	GOLDMAN SACHS GROUP INC	10.799	5,6200	1.080	56,2000	60.690

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil Dato	Handle Dato	Form	Insider	Ticker	Sikkerhedstitel	Kode	Direkte	Dyrke motion Pris	Enhed Pris	Enheder Ændret	Værdi Ændret (1K)	Tilbage Muligheder	Tilbage Aktier
2022-01-06	2022-01-04	4	Morris Arlene	VIVE	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	1,26		22.000		22.000
2022-01-06	2022-01-04	4	JORN DEBORA	VIVE	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	1,26		22.000		22.000
2022-01-06	2022-01-04	4	Durbin Scott	VIVE	Incentive Stock Option (Right to Purchase)	A - Award	D	1,26		258.000		258.000
2022-01-06	2022-01-04	4	Robbins Jim B	VIVE	Incentive Stock Option (Right to Purchase)	A - Award	D	1,26		42.000		42.000
2022-01-06	2022-01-04	4	Basta Steven L	VIVE	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	1,26		48.000		48.000
2022-01-06	2022-01-04	4	Presnell Sharon Collins	VIVE	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	1,26		18.000		18.000
2021-12-17	2021-12-15	4	Robbins Jim B	VIVE	Common Stock	D - Sale to Issuer	D		1,4300	-36	-0		0
2021-12-17	2021-12-15	4	Durbin Scott	VIVE	Common Stock	D - Sale to Issuer	D		1,4000	-2	-0		10
2021-12-17	2021-12-15	4	Basta Steven L	VIVE	Common Stock	D - Sale to Issuer	D		1,4100	-28	-0		25
2021-06-25	2021-06-23	4	JORN DEBORA	VIVE	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	2,73		51.700		51.700
2021-06-25	2021-06-23	4	Durbin Scott	VIVE	Incentive Stock Option (Right to Purchase)	A - Award	D	2,73		655.300		655.300
2021-06-25	2021-06-23	4	Basta Steven L	VIVE	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	2,73		116.200		116.200
2021-06-25	2021-06-23	4	Presnell Sharon Collins	VIVE	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	2,73		39.000		39.000
2021-06-25	2021-06-23	4	Morris Arlene	VIVE	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	2,73		51.700		51.700
2021-06-25	2021-06-23	4	Robbins Jim B	VIVE	Incentive Stock Option (Right to Purchase)	A - Award	D	2,73		104.700		104.700
2021-01-22	2021-01-20	4	JORN DEBORA	VIVE	Restricted Stock Unit	A - Award	D			25.000		25.000
2021-01-22	2021-01-20	4	Durbin Scott	VIVE	Restricted Stock Unit	A - Award	D			243.000		243.000
2021-01-22	2021-01-20	4	Morris Arlene	VIVE	Restricted Stock Unit	A - Award	D			25.000		25.000
2021-01-22	2021-01-20	4	Robbins Jim B	VIVE	Restricted Stock Unit	A - Award	D			39.000		39.000
2021-01-22	2021-01-20	4	Presnell Sharon Collins	VIVE	Restricted Stock Unit	A - Award	D			25.000		25.000
2021-01-22	2021-01-20	4	Basta Steven L	VIVE	Restricted Stock Unit	A - Award	D			50.000		50.000
2020-10-30	2020-10-28	4	Presnell Sharon Collins	VIVE	Non-Qualified Stock Option (Right to Buy)	A - Award	D	0,51		330.000		330.000
2020-09-22	2020-09-21	4	JORN DEBORA	VIVE	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	0,54		165.000		165.000
2020-09-22	2020-09-21	4	Morris Arlene	VIVE	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	0,54		165.000		165.000
2020-09-22	2020-09-21	4	Basta Steven L	VIVE	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	0,54		165.000		165.000
2020-02-18		3/A	GOLDMAN SACHS & CO See footnotes	VIVE	Common Units		I						53.042
2020-02-18	2019-10-01	4/A	GOLDMAN SACHS GROUP INC See Footnotes	VIVE	Common Units	S - Sale	I		5,7700	-25	-0		0
2020-02-18	2019-10-01	4/A	GOLDMAN SACHS GROUP INC See Footnotes	VIVE	Common Units	S - Sale	I		5,5600	-23.663	-132		25
2020-02-18	2019-09-30	4/A	GOLDMAN SACHS GROUP INC See Footnotes	VIVE	Common Units	S - Sale	I		4,5500	-68.737	-313		23.688
2020-02-18	2019-09-27	4/A	GOLDMAN SACHS GROUP INC See Footnotes	VIVE	Common Units	S - Sale	I		5,1000	-5.359	-27		92.425
2020-02-18	2019-09-26	4/A	GOLDMAN SACHS GROUP INC See Footnotes	VIVE	Common Units	S - Sale	I		5,2500	-7.001	-37		97.784
2020-02-18	2019-09-25	4/A	GOLDMAN SACHS GROUP INC See Footnotes	VIVE	Common Units	S - Sale	I		5,6200	-10.799	-61		104.785
2020-02-18	2019-09-24	4/A	GOLDMAN SACHS GROUP INC See Footnotes	VIVE	Common Units	S - Sale	I		5,5700	-800	-4		115.584
2020-02-18	2019-09-24	4/A	GOLDMAN SACHS GROUP INC See Footnotes	VIVE	Common Units	P - Purchase	I		5,6400	26.200	148		116.384
2020-02-18	2019-09-23	4/A	GOLDMAN SACHS GROUP INC See Footnotes	VIVE	Common Units	S - Sale	I		6,0500	-800	-5		90.184
2020-02-18	2019-09-23	4/A	GOLDMAN SACHS GROUP INC See Footnotes	VIVE	Common Units	P - Purchase	I		5,8400	39.600	231		90.984
2020-02-18	2019-09-20	4/A	GOLDMAN SACHS GROUP INC See Footnotes	VIVE	Common Units	S - Sale	I			-1.658			51.384
2019-11-27	2019-11-26	4	Zaderej Karen L.	VIVE	Non-Qualified Stock Option (Right to Buy)	A - Award	D	0,87		330.000		330.000
2019-11-27	2019-11-26	4	Robbins Jim B	VIVE	Non-Qualified Stock Option (Right to Buy)	A - Award	D	0,87		330.000		330.000
2019-11-27	2019-11-26	4	JORN DEBORA	VIVE	Non-Qualified Stock Option (Right to Buy)	A - Award	D	0,87		330.000		330.000
2019-11-27	2019-11-26	4	Morris Arlene	VIVE	Non-Qualified Stock Option (Right to Buy)	A - Award	D	0,87		330.000		330.000
2019-11-27	2019-11-26	4	Basta Steven L	VIVE	Non-Qualified Stock Option (Right to Buy)	A - Award	D	0,87		660.000		660.000
2019-11-27	2019-11-26	4	Durbin Scott	VIVE	Non-Qualified Stock Option (Right to Buy)	A - Award	D	0,87		3.298.000		3.298.000
2019-10-23	2019-09-27	4/A	GOLDMAN SACHS GROUP INC See Footnotes	VIVE	Common Units	S - Sale	I		5,1000	-5.359	-27		92.425
2019-10-23	2019-09-26	4/A	GOLDMAN SACHS GROUP INC See Footnotes	VIVE	Common Units	S - Sale	I		5,2500	-7.001	-37		97.784
2019-10-23	2019-09-25	4/A	GOLDMAN SACHS GROUP INC See Footnotes	VIVE	Common Units	S - Sale	I		5,6200	-10.799	-61		104.785
2019-10-23	2019-09-24	4/A	GOLDMAN SACHS GROUP INC See Footnotes	VIVE	Common Units	S - Sale	I		5,5700	-800	-4		115.584
2019-10-23	2019-09-24	4/A	GOLDMAN SACHS GROUP INC See Footnotes	VIVE	Common Units	P - Purchase	I		5,6400	26.200	148		116.384
2019-10-23	2019-09-23	4/A	GOLDMAN SACHS GROUP INC See Footnotes	VIVE	Common Units	S - Sale	I		6,0500	-800	-5		90.184
2019-10-23	2019-09-23	4/A	GOLDMAN SACHS GROUP INC See Footnotes	VIVE	Common Units	P - Purchase	I		5,8400	39.600	231		90.984
2019-10-23	2019-09-20	4/A	GOLDMAN SACHS GROUP INC See Footnotes	VIVE	Common Units	S - Sale	I		6,9000	-1.658	-11		51.384
2019-10-23	2019-10-01	4/A	GOLDMAN SACHS GROUP INC See Footnotes	VIVE	Common Units	S - Sale	I		5,7700	-25	-0		0
2019-10-23	2019-10-01	4/A	GOLDMAN SACHS GROUP INC See Footnotes	VIVE	Common Units	S - Sale	I		5,5600	-23.663	-132		25
2019-10-23	2019-09-30	4/A	GOLDMAN SACHS GROUP INC See Footnotes	VIVE	Common Units	S - Sale	I		4,5500	-68.737	-313		23.688
2019-10-02	2019-10-01	4	GOLDMAN SACHS GROUP INC See footnotes	VIVE	Common Units	S - Sale	I		5,5600	-23.688	-132		0
2019-10-02	2019-09-30	4	GOLDMAN SACHS GROUP INC See footnotes	VIVE	Common Units	S - Sale	I		4,5500	-68.737	-313		23.688
2019-09-30		3	GOLDMAN SACHS & CO See footnotes	VIVE	Common Units		I						106.084
2019-09-30		3	GOLDMAN SACHS & CO See footnotes	VIVE	Common Units		I						106.084
2019-09-30		3	GOLDMAN SACHS & CO See footnotes	VIVE	Common Units		I						106.084
2019-09-30		3	GOLDMAN SACHS & CO See footnotes	VIVE	Common Units		I						106.084
2019-09-30	2019-09-27	4	GOLDMAN SACHS GROUP INC See footnotes	VIVE	Common Units	S - Sale	I		5,0200	-5.359	-27		92.425
2019-09-30	2019-09-26	4	GOLDMAN SACHS GROUP INC See footnotes	VIVE	Common Units	S - Sale	I		5,2500	-7.001	-37		97.784
2019-09-30	2019-09-25	4	GOLDMAN SACHS GROUP INC See footnotes	VIVE	Common Units	S - Sale	I		5,6300	-10.799	-61		104.785
2019-09-30	2019-09-24	4	GOLDMAN SACHS GROUP INC See footnotes	VIVE	Common Units	P - Purchase	I		5,6500	25.400	144		115.584
2019-09-30	2019-09-23	4	GOLDMAN SACHS GROUP INC See footnotes	VIVE	Common Units	P - Purchase	I		5,8400	38.800	227		90.184
2019-09-30	2019-09-20	4	GOLDMAN SACHS GROUP INC See footnotes	VIVE	Common Units	S - Sale	I		7,5300	-1.658	-12		51.384
2019-07-02	2019-07-01	4	Zaderej Karen L.	VIVE	Common Stock	A - Award	D			37.829			62.347
2019-05-31	2019-05-29	4	Basta Steven L	VIVE	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	0,58		35.000		35.000
2019-05-31	2019-05-29	4	JORN DEBORA	VIVE	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	0,58		35.000		35.000
2019-05-31	2019-05-29	4	Morris Arlene	VIVE	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	0,58		35.000		35.000
2019-05-31	2019-05-29	4	Zaderej Karen L.	VIVE	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	0,58		35.000		35.000
2019-05-07		3/A	Mack Daniel Please see footnotes below.	VIVE	Common Stock		I						6.581.465
2019-05-03		3	Nantahala Capital Management, LLC Please see footnotes below.	NONE	Common Stock		I						13.162.930
2019-05-03		3	Nantahala Capital Management, LLC Please see footnotes below.	NONE	Common Stock		I						13.162.930
2019-05-03		3	Nantahala Capital Management, LLC Please see footnotes below.	NONE	Common Stock		I						13.162.930
2019-04-03	2019-04-01	4	Basta Steven L	VIVE	Common Stock	A - Award	D			24.199			24.199
2019-04-03	2019-04-01	4	Zaderej Karen L.	VIVE	Common Stock	A - Award	D			14.248			24.518
2019-04-03	2019-04-01	4	JORN DEBORA	VIVE	Common Stock	A - Award	D			10.280			40.109
2019-02-08	2019-01-29	4	Atkinson James G.	VIVE	Common Stock	A - Award	D			42.420			53.945
2019-02-08	2019-01-29	4	Durbin Scott	VIVE	Common Stock	A - Award	D			62.250			73.818
2019-02-08	2019-01-29	4	Robbins Jim B	VIVE	Common Stock	A - Award	D			27.778			145.346
2019-01-16	2019-01-15	4	Durbin Scott	VIVE	Incentive Stock Option (Right to Purchase)	A - Award	D	1,24		630.000		630.000
2019-01-16	2019-01-15	4	Robbins Jim B	VIVE	Incentive Stock Option (Right to Purchase)	A - Award	D	1,24		95.000		95.000
2019-01-16	2019-01-15	4	Atkinson James G.	VIVE	Incentive Stock Option (Right to Purchase)	A - Award	D	1,24		300.000		300.000
2019-01-16	2019-01-15	4	Basta Steven L	VIVE	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	1,24		35.000		35.000
2019-01-02	2018-12-31	4	JANNEY DANIEL	VIVE	Common Stock	A - Award	D			21.131			60.579
2019-01-02	2018-12-31	4	Zaderej Karen L.	VIVE	Common Stock	A - Award	D			9.524			10.270
2019-01-02	2018-12-31	4	JORN DEBORA	VIVE	Common Stock	A - Award	D			10.120			29.829
2018-10-25	2018-10-23	4	JANNEY DANIEL	VIVE	Non-qualified Stock Option (Right to Purchase)	A - Award	D	3,47		17.500		17.500
2018-10-25	2018-10-23	4	JORN DEBORA	VIVE	Non-qualified Stock Option (Right to Purchase)	A - Award	D	3,47		17.500		17.500
2018-10-25	2018-10-23	4	Morris Arlene	VIVE	Non-qualified Stock Option (Right to Purchase)	A - Award	D	3,47		17.500		17.500
2018-10-04	2018-10-01	4	Plexico Jon M	VIVE	Common Stock	A - Award	D			4.007			22.548
2018-10-04	2018-10-01	4	JORN DEBORA	VIVE	Common Stock	A - Award	D			4.285			19.709
2018-10-04	2018-10-01	4	Zaderej Karen L.	VIVE	Common Stock	A - Award	D			746			746
2018-10-04	2018-10-01	4	JANNEY DANIEL	VIVE	Common Stock	A - Award	D			8.947			39.448
2018-09-14	2018-09-13	4	Zaderej Karen L.	VIVE	Non-Qualified Stock Options	A - Award	D	3,45		70.000		70.000
2018-09-14	2018-09-13	4	Basta Steven L	VIVE	Non-Qualified Stock Options	A - Award	D	3,45		70.000		70.000
2018-09-13		3	Basta Steven L	VIVE	Common Stock		D						28.985
2018-09-13		3	Basta Steven L	VIVE	Common Stock		I						54.970
2018-09-13		3	Basta Steven L	VIVE	Common Stock		D						28.985
2018-09-13		3	Basta Steven L	VIVE	Common Stock		I						54.970
2018-09-13		3	Basta Steven L	VIVE	Common Stock		D						28.985
2018-09-13		3	Basta Steven L	VIVE	Common Stock		I						54.970
2018-07-03	2018-07-02	4	Plexico Jon M	VIVE	Common Stock	A - Award	D			4.635			18.541
2018-07-03	2018-07-02	4	BUSH LORI H	VIVE	Common Stock	A - Award	D			1.166			6.530
2018-07-03	2018-07-02	4	JANNEY DANIEL	VIVE	Common Stock	A - Award	D			8.437			30.501
2018-07-03	2018-07-02	4	JORN DEBORA	VIVE	Common Stock	A - Award	D			4.040			15.424
2018-05-23	2018-05-22	4	JORN DEBORA	VIVE	Non-qualified Stock Option (Right to Purchase)	A - Award	D	1,75		17.500		17.500
2018-05-23	2018-05-22	4	Plexico Jon M	VIVE	Non-qualified Stock Option (Right to Purchase)	A - Award	D	1,75		17.500		17.500
2018-05-23	2018-05-22	4	Morris Arlene	VIVE	Non-qualified Stock Option (Right to Purchase)	A - Award	D	1,75		17.500		17.500
2018-05-23	2018-05-22	4	JANNEY DANIEL	VIVE	Non-qualified Stock Option (Right to Purchase)	A - Award	D	1,75		17.500		17.500
2018-05-15	2018-05-11	4	Durbin Scott	VIVE	Stock Options (Right to Purchase)	A - Award	D	1,97		300.000		300.000
2018-05-15	2018-05-11	4	Robbins Jim B	VIVE	Stock Options (Right to Purchase)	A - Award	D	1,97		32.500		32.500
2018-05-15	2018-05-11	4	JORN DEBORA	VIVE	Stock Options (Right to Purchase)	A - Award	D	1,97		150.000		150.000
2018-04-04	2018-04-02	4	Plexico Jon M	VIVE	Common Stock	A - Award	D			3.543			13.906
2018-04-04	2018-04-02	4	JORN DEBORA	VIVE	Common Stock	A - Award	D			3.089			11.384
2018-04-04	2018-04-02	4	JANNEY DANIEL	VIVE	Common Stock	A - Award	D			6.450			22.064
2018-04-04	2018-04-02	4	BUSH LORI H	VIVE	Common Stock	A - Award	D			1.590			5.364
2018-01-25	2018-01-23	4	Scheller Patricia	VIVE	Incentive Stock Option (Right to Purchase)	A - Award	D	4,48		185.000		185.000
2018-01-25	2018-01-23	4	Robbins Jim B	VIVE	Incentive Stock Option (Right to Purchase)	A - Award	D	4,48		58.750		58.750
2018-01-25	2018-01-23	4	Atkinson James G.	VIVE	Incentive Stock Option (Right to Purchase)	A - Award	D	4,48		150.000		150.000
2018-01-25	2018-01-23	4	Durbin Scott	VIVE	Incentive Stock Option (Right to Purchase)	A - Award	D	4,48		120.000		120.000
2018-01-04	2018-01-02	4	JANNEY DANIEL	VIVE	Common Stock	A - Award	D			4.276			15.614
2018-01-04	2018-01-02	4	JORN DEBORA	VIVE	Common Stock	A - Award	D			2.048			8.295
2018-01-04	2018-01-02	4	Plexico Jon M	VIVE	Common Stock	A - Award	D			2.349			10.363
2018-01-04	2018-01-02	4	BUSH LORI H	VIVE	Common Stock	A - Award	D			964			3.774
2017-10-04	2017-10-02	4	JANNEY DANIEL	VIVE	Common Stock	A - Award	D			2.872			11.338
2017-10-04	2017-10-02	4	Plexico Jon M	VIVE	Common Stock	A - Award	D			2.196			8.014
2017-10-04	2017-10-02	4	JORN DEBORA	VIVE	Common Stock	A - Award	D			1.915			6.247
2017-10-04	2017-10-02	4	BUSH LORI H	VIVE	Common Stock	A - Award	D			901			2.810
2017-09-08	2017-09-06	4	JORN DEBORA	VIVE	Non-qualified Stock Option (Right to Purchase)	A - Award	D	5,58		17.500		17.500
2017-09-08	2017-09-06	4	JORN DEBORA	VIVE	Common Stock	A - Award	D			1.737			4.332
2017-09-08	2017-09-06	4	JANNEY DANIEL	VIVE	Non-qualified Stock Option (Right to Purchase)	A - Award	D	5,58		17.500		17.500
2017-09-08	2017-09-06	4	JANNEY DANIEL	VIVE	Common Stock	A - Award	D			3.025			8.466
2017-09-08	2017-09-06	4	BUSH LORI H	VIVE	Non-qualified Stock Option (Right to Purchase)	A - Award	D	5,58		17.500		17.500
2017-09-08	2017-09-06	4	Morris Arlene	VIVE	Non-qualified Stock Option (Right to Purchase)	A - Award	D	5,58		17.500		17.500
2017-09-08	2017-09-06	4	Plexico Jon M	VIVE	Non-qualified Stock Option (Right to Purchase)	A - Award	D	5,58		17.500		17.500
2017-09-08	2017-09-06	4	Plexico Jon M	VIVE	Common Stock	A - Award	D			2.185			5.818
2017-08-23	2017-08-23	4	Durbin Scott	VIVE	Common Stock	P - Purchase	D		5,2500	5.000	26		11.568
2017-05-22	2017-05-17	4/A	Plexico Jon M	VIVE	Common Stock	A - Award	D			1.724			3.633
2017-05-19	2017-05-17	4	JANNEY DANIEL	VIVE	Common Stock	A - Award	D			2.387			5.441
2017-05-19	2017-05-17	4	JANNEY DANIEL	VIVE	Common Stock	A - Award	D			2.387			5.441
2017-05-19	2017-05-17	4	Plexico Jon M	VIVE	Common Stock	A - Award	D			1.592			3.501
2017-05-19	2017-05-17	4	Plexico Jon M	VIVE	Common Stock	A - Award	D			1.592			3.501
2017-05-19	2017-05-17	4	JORN DEBORA	VIVE	Common Stock	A - Award	D			686			2.595
2017-03-21	2017-03-17	4	Stonepine Capital Management, LLC See Notes	VIVE	Common Stock	P - Purchase	I		4,0000	1.250.000	5.000		3.849.711
2017-03-21	2017-03-17	4	Atkinson James G. By Trust	VIVE	Common Stock	P - Purchase	I		4,0000	187.500	750		285.599
2017-03-21	2017-03-17	4	Atkinson James G. By IRA	VIVE	Common Stock	P - Purchase	I		4,0000	187.500	750		285.599
2017-03-21	2017-03-17	4	Scheller Patricia	VIVE	Common Stock	P - Purchase	D		4,0000	12.500	50		45.164
2017-03-21	2017-03-17	4	JANNEY DANIEL See Footnotes	VIVE	Common Stock	P - Purchase	I		4,0000	500.000	2.000		1.381.955
2017-03-07	2017-03-03	4	Durbin Scott	VIVE	Incentive Stock Option (Right to Purchase)	A - Award	D	4,46		132.860		132.860
2016-12-28	2016-12-23	4	BUSH LORI H	VIVE	Non-qualified Stock Option (Right to Purchase)	A - Award	D	5,22		25.160		25.160
2016-12-28	2016-12-23	4	JORN DEBORA	VIVE	Non-qualified Stock Option (Right to Purchase)	A - Award	D	5,22		25.160		25.160
2016-12-28	2016-12-23	4	Plexico Jon M	VIVE	Non-qualified Stock Option (Right to Purchase)	A - Award	D	5,22		25.160		25.160
2016-12-28	2016-12-23	4	JANNEY DANIEL	VIVE	Non-qualified Stock Option (Right to Purchase)	A - Award	D	5,22		11.035		11.035
2016-12-28	2016-12-23	4	Morris Arlene	VIVE	Non-qualified Stock Option (Right to Purchase)	A - Award	D	5,22		25.160		25.160
2016-12-28	2016-12-23	4	Scheller Patricia	VIVE	Incentive Stock Option (Right to Purchase)	A - Award	D	5,22		150.000		150.000
2016-12-28	2016-12-23	4	Durbin Scott	VIVE	Incentive Stock Option (Right to Purchase)	A - Award	D	5,22		50.000		50.000
2016-12-28	2016-12-23	4	Atkinson James G.	VIVE	Incentive Stock Option (Right to Purchase)	A - Award	D	5,22		2.250		2.250
2016-12-28	2016-12-23	4	Atkinson James G.	VIVE	Incentive Stock Option (Right to Purchase)	A - Award	D	5,22		75.000		75.000
2016-11-14	2016-11-09	4	Plexico Jon M	VIVE	Common Stock	A - Award	D			1.109			1.909
2016-11-14	2016-11-09	4	Morris Arlene	VIVE	Common Stock	A - Award	D			1.442			2.482
2016-11-14	2016-11-09	4	JORN DEBORA	VIVE	Common Stock	A - Award	D			1.109			1.909
2016-11-14	2016-11-09	4	JANNEY DANIEL	VIVE	Common Stock	A - Award	D			1.775			3.054
2016-11-14	2016-11-09	4	BUSH LORI H	VIVE	Common Stock	A - Award	D			1.109			1.909
2016-08-24	2016-08-22	4	JORN DEBORA	VIVE	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	7,89		4.590		4.590
2016-08-24	2016-08-22	4	JORN DEBORA	VIVE	Common Stock	A - Award	D			800			800
2016-08-24	2016-08-22	4	Morris Arlene	VIVE	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	7,89		4.590		4.590
2016-08-24	2016-08-22	4	Morris Arlene	VIVE	Common Stock	A - Award	D			1.040			1.040
2016-08-24	2016-08-22	4	JANNEY DANIEL	VIVE	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	7,89		4.590		4.590
2016-08-24	2016-08-22	4	JANNEY DANIEL	VIVE	Common Stock	A - Award	D			1.279			1.279
2016-08-24	2016-08-22	4	BUSH LORI H	VIVE	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	7,89		4.590		4.590
2016-08-24	2016-08-22	4	BUSH LORI H	VIVE	Common Stock	A - Award	D			800			800
2016-08-24	2016-08-22	4	Plexico Jon M	VIVE	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	7,89		4.590		4.590
2016-08-24	2016-08-22	4	Plexico Jon M	VIVE	Common Stock	A - Award	D			800			800
2016-08-24	2016-08-22	4	Smith Brigitte	VIVE	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	7,89		4.590		4.590
2016-08-24	2016-08-22	4	Smith Brigitte	VIVE	Common Stock	A - Award	D			1.279			25.312
2016-06-21	2016-06-17	4	Atkinson James G. By IRA	VIVE	Common Stock	P - Purchase	I		5,0000	100.000	500		433.737
2016-06-21	2016-06-17	4	Scheller Patricia	VIVE	Common Stock	P - Purchase	D		5,0000	6.000	30		32.664
2016-06-21	2016-06-17	4	Durbin Scott	VIVE	Common Stock	P - Purchase	D		5,0000	1.500	8		6.568
2016-06-21	2016-06-17	4	Stonepine Capital Management, LLC See	VIVE	Common Stock	P - Purchase	I		5,0000	300.000	1.500		2.599.711
2016-06-20	2016-06-17	4	JANNEY DANIEL See Footnotes	VIVMF	Common Stock	P - Purchase	I		5,0000	200.000	1.000		881.954
2016-05-20	2016-05-11	4	JORN DEBORA	VIVMF	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	7,74		5.250		5.250
2016-05-20	2016-05-11	4	BUSH LORI H	VIVMF	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	7,74		5.250		5.250
2016-05-20	2016-05-11	4	Morris Arlene	VIVMF	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	7,74		5.250		5.250
2016-05-13	2016-05-11	4	Plexico Jon M	VIVMF	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	7,74		5.250		5.250
2016-04-29	2015-08-05	4/A	Scheller Patricia	VIVMF	Common Stock	P - Purchase	D		1,0451	526	1		135.662
2016-03-23		3	Plexico Jon M By Limited Partnership	VIVMF	Common Stock		I						36.795.364
2016-03-23		3	Plexico Jon M By Limited Partnership	VIVMF	Common Stock		I						36.795.364
2016-03-15	2016-01-04	4	Scheller Patricia	VIVMF	Common Stock	A - Award	D			58.597			213.815
2016-03-15	2016-01-04	4	Atkinson James G.	VIVMF	Common Stock	F - Taxes	D		0,7800	-54.798	-43		92.194
2016-03-15	2016-01-04	4	Atkinson James G.	VIVMF	Common Stock	A - Award	D			146.992			146.992
2016-03-15	2016-01-04	4	Robbins Jim B	VIVMF	Common Stock	A - Award	D			50.000			117.568
2016-02-29	2016-02-25	4	Scheller Patricia	VIVMF	Common Stock	P - Purchase	D		0,8500	588	0		155.218
2016-01-29	2016-01-27	4	JANNEY DANIEL See Footnotes	VIVMF	Warrant to Purchase Common Stock	P - Purchase	I	0,53	0,3500	202.000	71	202.000
2016-01-27	2016-01-25	4	Scheller Patricia	VIVMF	Common Stock	P - Purchase	D		0,7000	1.428	1		154.630
2015-12-28	2015-12-23	4	Scheller Patricia	VIVMF	Common Stock	P - Purchase	D		0,7354	1.359	1		153.202
2015-12-22	2015-02-17	4	Robbins Jim B	VIVMF	Warrant to Purchase Common Stock	A - Award	D	0,50		43.024		58.024
2015-12-18	2015-12-16	4	Scheller Patricia	VIVMF	Incentive Stock Option (Right to Purchase)	A - Award	D	0,75		1.936.001		3.097.180
2015-12-18	2015-12-16	4	Colella Mark Samuel	VIVMF	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	0,75		108.000		155.000
2015-12-18	2015-12-16	4	Atkinson James G.	VIVMF	Warrant to Purchase Common Stock	A - Award	D	0,70		50.000		267.733
2015-12-18	2015-12-16	4	Atkinson James G.	VIVMF	Incentive Stock Option (Right to Purchase)	A - Award	D	0,75		704.000		1.239.000
2015-12-18	2015-12-16	4	Smith Brigitte	VIVMF	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	0,75		108.000		155.000
2015-12-18	2015-12-16	4	JANNEY DANIEL	VIVMF	Non-Qualified Stock Option (Right to Purchase)	A - Award	D	0,75		108.000		155.000
2015-12-18	2015-12-16	4	Durbin Scott	VIVMF	Incentive Stock Option (Right to Purchase)	A - Award	D	0,75		774.001		1.239.000
2015-12-18	2015-12-16	4	Robbins Jim B	VIVMF	Warrant to Purchase Common Stock	A - Award	D	0,70		15.000		15.000
2015-12-18	2015-12-16	4	Robbins Jim B	VIVMF	Incentive Stock Option (Right to Purchase)	A - Award	D	0,75		194.000		310.000
2015-12-18	2015-12-16	4	Simpson Carl	VIVMF	Non-QualifiedStock Option (Right to Purchase)	A - Award	D	0,75		108.000		156.811
2015-11-27	2015-11-24	4	Scheller Patricia	VIVMF	Common Stock	P - Purchase	D		0,7000	14.285	10		151.843
2015-11-27	2015-11-24	4	Atkinson James G. By Trust	VIVMF	Common Stock	P - Purchase	I		0,7000	109.105	76		3.485.264
2015-11-27	2015-11-24	4	Atkinson James G. IRA	VIVMF	Common Stock	P - Purchase	I		0,7000	642.857	450		3.376.159
2015-11-25	2015-11-24	4	Alta Bioequities Management, LLC See Footnotes	VIVMF	Common Stock	P - Purchase	I		0,7000	857.142	600		5.455.632
2015-11-25	2015-11-24	4	STONEPINE CAPITAL, L.P.	VIVMF	Common Stock	P - Purchase	D		0,7000	2.857.142	2.000		18.397.682
2015-11-25	2015-11-24	4	JANNEY DANIEL See Footnotes	VIVMF	Common Stock	P - Purchase	I		0,7000	857.142	600		5.455.632
2015-11-23	2015-11-17	4	Scheller Patricia	VIVMF	Common Stock	P - Purchase	D		0,7600	10	0		137.558
2015-11-23	2015-11-17	4	Scheller Patricia	VIVMF	Common Stock	P - Purchase	D		0,7300	1.360	1		137.548
2015-08-11	2015-08-05	4	Scheller Patricia	VIVMF	Common Stock	P - Purchase	D		1,0451	526	1		136.188
2015-08-11	2015-08-05	4	Scheller Patricia	VIVMF	Common Stock	P - Purchase	D		0,8549	526	0		135.662
2015-07-22	2015-06-12	4	Atkinson James G. By Custodian for Child	VIVMF	Common Stock	P - Purchase	I		0,8990	30.600	28		2.733.302
2015-05-29	2015-05-14	4	5AM Partners II, LLC See	VIVMF	Common Stock	P - Purchase	I		0,3700	25.649	9		288.447
2015-05-29	2015-05-14	4	5AM Partners II, LLC See	VIVMF	Common Stock	P - Purchase	I		0,3700	650.026	241		7.310.231
2015-05-29	2015-05-14	4	Colella Mark Samuel See	VIVMF	Common Stock	P - Purchase	I		0,3700	25.649	9		288.447
2015-05-29	2015-05-14	4	Colella Mark Samuel See	VIVMF	Common Stock	P - Purchase	I		0,3700	650.026	241		7.310.231
2015-05-28	2015-05-12	4	Atkinson James G.	VIVMF	Warrant to Purchase Common Stock	A - Award	D	0,53		217.733		217.733
2015-05-21	2015-05-12	4/A	Atkinson James G. By Trust	VIVMF	Common Stock	P - Purchase	I		0,3700	675.675	250		2.702.702
2015-05-21	2015-05-12	4/A	Atkinson James G. By IRA	VIVMF	Common Stock	P - Purchase	I		0,3700	2.027.027	750		2.027.027
2015-05-21		3	STONEPINE CAPITAL, L.P.	VIVMF	Common Stock		D						31.081.080
2015-05-21		3	STONEPINE CAPITAL, L.P.	VIVMF	Common Stock		D						31.081.080
2015-05-14	2015-05-12	4	Scheller Patricia	VIVMF	Common Stock	P - Purchase	D		0,3700	135.136	50		135.136
2015-05-14	2015-05-12	4	Robbins Jim B	VIVMF	Common Stock	P - Purchase	D		0,3700	67.568	25		67.568
2015-05-14	2015-05-12	4	Durbin Scott	VIVMF	Common Stock	P - Purchase	D		0,3700	40.541	15		40.541
2015-05-14	2015-05-12	4	Atkinson James G. By Trust	VIVMF	Common Stock	P - Purchase	I		0,3700	675.675	250		3.378.377
2015-05-14	2015-05-12	4	Atkinson James G. By IRA	VIVMF	Common Stock	P - Purchase	I		0,3700	2.702.702	1.000		2.702.702
2015-05-14	2015-05-12	4	JANNEY DANIEL See footnotes.	VIVMF	Common Stock	P - Purchase	I		0,3700	2.702.702	1.000		4.598.490
2015-05-14	2015-05-12	4	Alta Bioequities Management, LLC See footnotes.	VIVMF	Common Stock	P - Purchase	I		0,3700	2.702.702	1.000		4.598.490
2015-02-18	2015-02-17	4	Scheller Patricia	VIVMF	Common Stock Warrant	A - Award	D	0,50		205.814		205.814
2015-02-18	2015-02-17	4	Durbin Scott	VIVMF	Common Stock Warrant	A - Award	D	0,50		208.140		208.140
2014-10-02	2014-09-23	4	GBS Venture Partners Pty, Ltd	PLCSD	Common Stock	P - Purchase	D		0,5300	947.872	502		3.598.807
2014-10-02	2014-09-23	4	GBS Venture Partners Pty, Ltd See footnotes	PLCSD	Common Stock	P - Purchase	I		0,5300	947.872	502		3.598.807
2014-10-02		3	GBS Bioventures III A/C	PLCSD	Common Stock		D						7.952.805
2014-10-02		3	GBS Bioventures III A/C See footnotes	PLCSD	Common Stock		I						7.952.805
2014-10-02		3	GBS Bioventures III A/C	PLCSD	Common Stock		D						7.952.805
2014-10-02		3	GBS Bioventures III A/C See footnotes	PLCSD	Common Stock		I						7.952.805
2014-10-02		3	GBS Bioventures III A/C See footnotes	PLCSD	Common Stock		I						7.952.805
2014-10-02		3	GBS Bioventures III A/C	PLCSD	Common Stock		D						7.952.805
2014-09-30	2014-09-26	4	Colella Mark Samuel	PLCSD	Non-Qualified Stock Option	A - Award	D	0,60		47.000		47.000
2014-09-30	2014-09-26	4	Scheller Patricia	PLCSD	Incentive Stock Option	A - Award	D	0,60		939.318		939.318
2014-09-30	2014-09-26	4	Smith Brigitte	PLCSD	Non-Qualified Stock Option	A - Award	D	0,60		47.000		47.000
2014-09-30	2014-09-23	4	Smith Brigitte	PLCSD	Common Stock	P - Purchase	D		0,5300	192.262	102		3.791.069
2014-09-30	2014-09-23	4	Smith Brigitte See Footnotes	PLCSD	Common Stock	P - Purchase	I		0,5300	947.872	502		3.598.807
2014-09-30	2014-09-26	4	Durbin Scott	PLCSD	Incentive Stock Option	A - Award	D	0,60		382.420		382.420
2014-09-30	2014-09-26	4	Robbins Jim B	PLCSD	Incentive Stock Option	A - Award	D	0,60		116.000		116.000
2014-09-30	2014-09-26	4	Simpson Carl	PLCSD	Non-Qualified Stock Option	A - Award	D	0,60		47.000		47.000
2014-09-30	2014-09-26	4	JANNEY DANIEL	PLCSD	Non-Qualified Stock Option	A - Award	D	0,60		47.000		47.000
2014-09-30		3	Smith Brigitte See footnotes	PLCSD	Common Stock		I						5.301.870
2014-09-30		3	Smith Brigitte See footnotes	PLCSD	Common Stock		I						5.301.870
2014-09-26		3	Simpson Carl	PLCSD	Common Stock		D						30.768
2014-09-26		3	Simpson Carl	PLCSD	Common Stock		D						30.768
2014-09-26		3	Alta Bioequities, L.P. See footnotes	PLCSD	Common Stock		I						3.791.576
2014-09-26		3	Alta Bioequities, L.P. See footnotes	PLCSD	Common Stock		I						3.791.576
2014-09-26		3	Alta Bioequities, L.P. See footnotes	PLCSD	Common Stock		I						3.791.576
2014-09-26		3	Alta Bioequities, L.P. See footnotes	PLCSD	Common Stock		I						3.791.576
2014-09-25		3	DIEKMAN JOHN D	PLCSD	Common Stock		I						3.349.867
2014-09-25		3	DIEKMAN JOHN D	PLCSD	Common Stock		I						1.772.150
2014-09-25		3	DIEKMAN JOHN D	PLCSD	Common Stock		I						3.349.867
2014-09-25		3	DIEKMAN JOHN D	PLCSD	Common Stock		I						1.772.150
2014-09-25		3	DIEKMAN JOHN D	PLCSD	Common Stock		I						3.349.867
2014-09-25		3	DIEKMAN JOHN D	PLCSD	Common Stock		I						1.772.150
2014-09-25		3	DIEKMAN JOHN D	PLCSD	Common Stock		I						3.349.867
2014-09-25		3	DIEKMAN JOHN D	PLCSD	Common Stock		I						1.772.150
2014-09-25		3	DIEKMAN JOHN D	PLCSD	Common Stock		I						3.349.867
2014-09-25		3	DIEKMAN JOHN D	PLCSD	Common Stock		I						1.772.150
2014-09-25		3	DIEKMAN JOHN D	PLCSD	Common Stock		I						1.772.150
2014-09-25		3	DIEKMAN JOHN D	PLCSD	Common Stock		I						3.349.867
2014-09-25		3	DIEKMAN JOHN D	PLCSD	Common Stock		I						1.772.150
2014-09-25		3	DIEKMAN JOHN D	PLCSD	Common Stock		I						3.349.867
2014-09-25	2014-09-23	4	Colella Mark Samuel	PLCSD	Common Stock	P - Purchase	I		0,5300	197.987	105		262.798
2014-09-25	2014-09-23	4	Colella Mark Samuel	PLCSD	Common Stock	J - Other	I			64.811			64.811
2014-09-25	2014-09-23	4	Colella Mark Samuel	PLCSD	Common Stock	P - Purchase	I		0,5300	5.017.677	2.659		6.660.205
2014-09-25	2014-09-23	4	Colella Mark Samuel	PLCSD	Common Stock	J - Other	I			1.642.528			1.642.528
2014-09-25	2014-09-23	4	5AM Partners II, LLC	PLCSD	Common Stock	P - Purchase	I		0,5300	197.987	105		262.798
2014-09-25	2014-09-23	4	5AM Partners II, LLC	PLCSD	Common Stock	P - Purchase	I		0,5300	5.017.677	2.659		6.660.205
2014-09-25	2014-09-23	4	JANNEY DANIEL See footnotes	PLCSD	Common Stock	P - Purchase	I		0,5300	1.895.788	1.005		1.895.788
2013-07-22	2013-07-16	4	NORTON H B BRENT	PLCSF	Stock Option (Right to Buy)	A - Award	D	0,09		216.500		409.000
2013-07-22	2013-07-16	4	HOLMES BENJAMIN L	PLCSF	Stock Option (Right to Buy)	A - Award	D	0,09		272.800		515.300
2013-07-22	2013-07-16	4	Puglisi Vincent	PLCSF	Stock Option (Right to Buy)	A - Award	D	0,09		323.000		609.902
2013-07-22	2013-07-16	4	TAUSCHER MARK R	PLCSF	Stock Option (Right to Buy)	A - Award	D	0,09		1.908.565		3.537.565
2013-07-22	2013-07-16	4	Mann Gregory W.	PLCSF	Stock Option (Right to Buy)	A - Award	D	0,09		1.272.377		1.492.377
2012-06-01	2012-05-30	4	PENDERGAST EDWARD H	PLCSF	Stock Option (Right to Buy)	A - Award	D	0,17		45.000		45.000
2012-06-01	2012-05-30	4	TAUSCHER MARK R	plcsf	Stock Option (Right to Buy)	A - Award	D	0,17		70.000		70.000
2012-06-01	2012-05-30	4	DUNN KEVIN J	PLCSF	Stock Option (Right to Buy)	A - Award	D	0,17		22.500		22.500
2012-06-01	2012-05-30	4	NORTON H B BRENT	PLCSF	Stock Option (Right to Buy)	A - Award	D	0,17		22.500		22.500
2012-06-01	2012-05-30	4	HOLMES BENJAMIN L	PLCSF	Stock Option (Right to Buy)	A - Award	D	0,17		22.500		22.500
2012-06-01	2012-05-30	4	Puglisi Vincent	PLCSF	Stock Option (Right to Buy)	A - Award	D	0,17		40.000		40.000
2012-06-01	2012-05-30	4	Mann Gregory W.	plcsf	Stock Option (Right to Buy)	A - Award	D	0,17		70.000		70.000

Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer

Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer

Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)

Konvertering af derivat

Salg eller overførsel af værdipapirer tilbage til virksomheden

Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet

Gave af værdipapirer af eller til insideren

Aktieswaps og lignende sikringstransaktioner

Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)

En transaktion rapporteret frivilligt på formular 4

Andet (ledsaget af en fodnote, der beskriver transaktionen)

VIVE / Viveve Medical, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5